ORIC
ORIC Pharmaceuticals Inc

781
Mkt Cap
$1.15B
Volume
344,425.00
52W High
$14.93
52W Low
$3.90
PE Ratio
-6.83
ORIC Fundamentals
Price
$11.86
Prev Close
$11.82
Open
$12.02
50D MA
$12.36
Beta
1.40
Avg. Volume
1.45M
EPS (Annual)
-$1.83
P/B
2.83
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Oric Pharmaceuticals (NASDAQ:ORIC) Rating Lowered to Sell at Wall Street Zen
Wall Street Zen downgraded shares of Oric Pharmaceuticals from a "hold" rating to a "sell" rating in a research note on Sunday...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Oric Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up - Should You Buy?
Oric Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up - Time to Buy...
MarketBeat·7d ago
News Placeholder
Oric Pharmaceuticals (NASDAQ:ORIC) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
JPMorgan Chase & Co. increased their price target on Oric Pharmaceuticals from $17.00 to $20.00 and gave the company an "overweight" rating in a report on Tuesday...
MarketBeat·9d ago
News Placeholder
Wolfe Research Initiates Coverage on Oric Pharmaceuticals (NASDAQ:ORIC)
Wolfe Research assumed coverage on Oric Pharmaceuticals in a research note on Tuesday. They issued a "peer perform" rating for the company...
MarketBeat·9d ago
News Placeholder
Oric Pharmaceuticals (ORIC) Upgraded to Buy: Here's What You Should Know
Oric Pharmaceuticals (ORIC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·10d ago
News Placeholder
Oric Pharmaceuticals (NASDAQ:ORIC) Stock Price Expected to Rise, Citigroup Analyst Says
Citigroup upped their target price on Oric Pharmaceuticals from $12.00 to $16.00 and gave the stock a "buy" rating in a research report on Monday...
MarketBeat·10d ago
News Placeholder
Oric Pharmaceuticals' (ORIC) "Outperform" Rating Reaffirmed at Wedbush
Wedbush reaffirmed an "outperform" rating and issued a $20.00 price objective on shares of Oric Pharmaceuticals in a research report on Friday...
MarketBeat·12d ago
News Placeholder
Oric Pharmaceuticals (NASDAQ:ORIC) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen raised Oric Pharmaceuticals from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·12d ago
News Placeholder
Oric Pharmaceuticals (NASDAQ:ORIC) Price Target Raised to $15.00
Oppenheimer raised their target price on shares of Oric Pharmaceuticals from $12.00 to $15.00 and gave the stock an "outperform" rating in a report on Friday...
MarketBeat·13d ago
News Placeholder
Wells Fargo & Company Lowers Oric Pharmaceuticals (NASDAQ:ORIC) Price Target to $19.00
Wells Fargo & Company dropped their target price on shares of Oric Pharmaceuticals from $20.00 to $19.00 and set an "overweight" rating on the stock in a research report on Friday...
MarketBeat·13d ago

Latest ORIC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.